Химиотерапия рецидивов и метастазов плоскоклеточного рака головы и шеи с использованием цетуксимаба
И. С. Романов, A Sh Taneeva, Л. П. Яковлева et al. · CyberLeninK (CyberLeninka) · 2011
Over 30 years, chemotherapy for recurrent and metastatic head and neck squamous-cell carcinoma (HNSCC) has remained practically unchanged; its gold standard has been a combination of cisplatin and 5-fluorouracil. The emergence of the target drug cetuximab has given head and neck tumor specialists a powerful tool to modify standard treatment regimens. The paper presents a brief literature review of the state-of-the-art of first-line chemotherapy for recurrent and metastatic HNSCC, as well as the authors clinical findings based on the analysis of treatment in 11 patients with recurrent HNSCC
Cited by 0 works.